Photo of Steven Frank from MD Anderson Cancer Center/X
Jun 5, 2024, 06:48
The results of this multi-center Phase III randomized trial by Steven Frank – MD Anderson Cancer Center
MD Anderson Cancer Center shared on X/Twitter:
” ‘The results of this multi-center Phase III randomized trial provide evidence for intensity modulated proton therapy as a new standard-of-care treatment approach for the management of head and neck tumors,’ says our Steven Frank of research presented at ASCO24. (Abstract 6006).”
Source: MD Anderson Cancer Center/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 20:46
Apr 21, 2025, 20:30
Apr 21, 2025, 20:11
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19
Apr 21, 2025, 18:00
Apr 21, 2025, 17:40
Apr 21, 2025, 17:35
Apr 21, 2025, 17:29